Evidence map›Paper›PMID 36598811›Full record

ArticleJournal of medical Internet research2023

Advancing Digital Health Innovation in Oncology: Priorities for High-Value Digital Transformation in Cancer Care.

Smit Patel, Jennifer C Goldsack, Grace Cordovano, Andrea Downing, Karen K Fields, Cindy Geoghegan, Upinder Grewal, Jorge Nieva, Nikunj Patel, Dana E Rollison and 7 more

Open access · goldAbstract read
In one paragraph

Article in Journal of medical Internet research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 2 pooled it
27.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 2 syntheses or guidelines pooled it, 48 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 8 institutions in 2 countries.

Smit PatelDigital Medicine Society, Boston, MA, United States.ORCID 0000-0002-9186-0430
Jennifer C GoldsackDigital Medicine Society, Boston, MA, United States.ORCID 0000-0003-0461-0183
Grace CordovanoEnlightening Results LLC, West Caldwell, NJ, United States.ORCID 0000-0002-5543-8726
Andrea DowningThe Light Collective, Shoreline, WA, United States.ORCID 0000-0001-8401-8686
Karen K FieldsCenter for Digital Health, Moffitt Cancer Center, Tampa, FL, United States.ORCID 0000-0002-2612-4998
Cindy GeogheganPatient and Partners LLC, Madison, CT, United States.ORCID 0000-0003-0992-3728
Upinder GrewalBayer AG, Reading, United Kingdom.ORCID 0000-0002-3216-9594
Jorge NievaNorris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA, United States.ORCID 0000-0003-1605-4719
Nikunj PatelAstraZeneca PLC, Gaithersburg, MD, United States.ORCID 0000-0001-8980-7246
Dana E RollisonCenter for Digital Health, Moffitt Cancer Center, Tampa, FL, United States.ORCID 0000-0002-3171-8045
Archana SahAS Pharma Advisors, Inc, San Francisco, CA, United States.ORCID 0000-0001-8539-785X
Maya SaidOutcomes4Me Inc, Boston, MA, United States.ORCID 0000-0002-1754-8852
Isabel Van De KeereImmersive Rehab, London, United Kingdom.ORCID 0000-0001-5920-0275
Amanda WayJazz Venture Partners, San Francisco, CA, United States.ORCID 0000-0001-6443-2820
Dana L Wolff-HughesDivision of Cancer Control and Populations Sciences, National Cancer Institute, Bethesda, MD, United States.ORCID 0000-0003-3280-9771
William A WoodLineberger Comprehensive Cancer Center, University of North Carolina Chapel Hill, Chapel Hill, NC, United States.ORCID 0000-0001-7439-2543
Edmondo J RobinsonCenter for Digital Health, Moffitt Cancer Center, Tampa, FL, United States.ORCID 0000-0001-9625-6235
Moffitt Cancer Center · USAstraZeneca (United States) · USBayer (United Kingdom) · GBHealth Outcomes Solutions (United States) · USNational Cancer Institute · USPartners In Care · USUniversity of North Carolina at Chapel Hill · USUniversity of Southern California · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Although health care delivery is becoming increasingly digitized, driven by the pursuit of improved access, equity, efficiency, and effectiveness, progress does not appear to be equally distributed across therapeutic areas. Oncology is renowned for leading innovation in research and in care; digital pathology, digital radiology, real-world data, next-generation sequencing, patient-reported outcomes, and precision approaches driven by complex data and biomarkers are hallmarks of the field. However, remote patient monitoring, decentralized approaches to care and research, "hospital at home," and machine learning techniques have yet to be broadly deployed to improve cancer care. In response, the Digital Medicine Society and Moffitt Cancer Center convened a multistakeholder roundtable discussion to bring together leading experts in cancer care and digital innovation. This viewpoint highlights the findings from these discussions, in which experts agreed that digital innovation is lagging in oncology relative to other therapeutic areas. It reports that this lag is most likely attributed to poor articulation of the challenges in cancer care and research best suited to digital solutions, lack of incentives and support, and missing standardized infrastructure to implement digital innovations. It concludes with suggestions for actions needed to bring the promise of digitization to cancer care to improve lives.

Indexed as

Delivery of Health CareNeoplasmsHumansPatient Reported Outcome Measuresbiomarkercancercancer caredigital dividedigital healthdigital innovationdigital transformationequityhealth care deliveryinnovationoncologypatient journeypatient-reported outcomePROMservice delivery

Identifiers

PMID36598811
PMCPMC9850283
OpenAlexW4313546103

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.